Why did you decide to participate in the Biomapas Academy?
The first time I heard about Biomapas Academy was from a friend who was already working in the pharmacy field. She sent me an advertisement for Biomapas Academy, which highly intrigued me. As I was in my last year of life science master studies, I wanted to discover my potential career possibilities and learn more about clinical trials. Therefore, without long thinking, I filled in the application form. I was very happy to be selected from quite many applicants and be invited to attend Biomapas Academy.
How was your experience during the three months?
We had four months of weekly lectures on different topics. They were related to the organization of clinical trials, regulatory affairs and pharmacovigilance of various medical products. Biomapas experts who resented the lectures even shared their personal experience and actual practical examples with us. We have been able to get acquainted with Biomapas company and its work specifics. Here we could expand our knowledge of the pharmaceutical industry.
How do you feel after graduating from the Academy?
I feel thrilled for taking a chance to participate in this unique project. After graduating from all the courses and tasks, I was absolutely honoured to be selected as the best student of Biomapas Academy 2020 and receive a scholarship. However, I mostly appreciate the valuable knowledge and experience I believe will be helpful for my future career. I think Biomapas Academy definitely contributes to the education of young professionals and is very useful, especially for those who want to get to know their professional opportunities better.
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
Outsourcing in Pharmacovigilance
Imagine a pharmaceutical company navigating the intricate labyrinth of drug development and patient safety. Amid these complexities, an intriguing solution has been emerging: pharmacovigilance outsourcing. This practice involves entrusting a part or the entirety of...
What is Functional Service Provision?
What is Functional Service Provision? And how can you best make use of its benefits in your clinical research programs?
Pharmacovigilance & Medical Information. An Integrated Approach
Learn how you can achieve an integration of Pharmacovigilance and Medical Information from our real-world experience.
How can a CRO support Mergers & Acquisition
The role of Contract Research Organizations (CROs) in supporting mergers and acquisitions (M&As) is not a new concept, as CROs have been providing services in this area for several years. However, the demand for these services may have increased in recent years...
Clinical Trial Design For Early Phase Oncology Studies
Designing effective early-phase oncology trials is a complex and challenging task, requiring careful consideration of various factors, including patient selection, dosing, safety monitoring, and endpoint selection. In addition, developing targeted therapies has...
Freelance Local Regulatory Affairs Specialist
Join our global team as a freelance Local Regulatory Affairs Specialist We have various freelance, part-time, remote vacancies of Local Regulatory Affairs Specialist (LRAS) for throughout Europe and CIS. Location: EU or CIS regions. Responsibilities: To...
Oncology Study Design
Join us for a must-attend webinar on “Exploring Oncology Clinical Trial Design”, where expert speakers will share the latest insights.
Setting Up Medical Information In Europe
Setting up a Medical Information Scientific Service The world of healthcare is constantly evolving, and one of the most exciting developments is the rise of medical information as a potential source of differentiation. Technological advances such as Global Medical...
National differences for Pharmacovigilance in Europe
Join our webinar on “Navigating National Differences in Setting up a Pharmacovigilance System in Europe.” 🇪🇺 💊
National Differences in Pharmacovigilance Requirements in Europe
Pharmacovigilance requirements in Europe are primarily governed by the European Medicines Agency (EMA) through the EU Regulation on Pharmacovigilance (Regulation (EU) No 1235/2010). However, some national differences in implementing and enforcing these requirements...
